Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral desensitization in Rh disease.

W R Gold, J T Queenan, J Woody

    American Journal of Obstetrics and Gynecology
    |August 15, 1983
    PubMed
    Summary

    This study explored erythrocyte membrane therapy for severe Rh disease. The treatment aimed to reduce anti-D antibody production in Rh-immunized pregnancies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.

    Neurology·2009
    Same author

    Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.

    Neurology·2003
    Same author

    Evidence-based recommendations for the use of WBC-reduced cellular blood components.

    Transfusion·2001
    Same author

    Intravenous immunoglobulin consensus statement.

    The Journal of allergy and clinical immunology·2001
    Same author

    Privacy lost.

    Obstetrics and gynecology·2001
    Same author

    Professional liability--some solutions.

    Obstetrics and gynecology·2001

    Area of Science:

    • Immunology
    • Obstetrics & Gynecology
    • Hematology

    Background:

    • Severe Rh disease poses significant risks to pregnancies.
    • Rh immunization can lead to erythroblastosis fetalis and fetal loss.
    • Managing Rh disease requires strategies to mitigate anti-D antibody production.

    Purpose of the Study:

    • To evaluate the efficacy of erythrocyte membrane oral therapy in managing severe Rh disease.
    • To assess the impact of this therapy on reducing anti-D antibody levels.
    • To present cases of pregnancies managed with this novel therapeutic approach.

    Main Methods:

    • Case series presentation of four pregnancies.
    • Management involved the administration of erythrocyte membrane oral therapy.
    • Severe Rh immunization was defined by a history of fetal loss before 26 weeks gestation.

    Main Results:

    • The study focused on the reduction of anti-D antibody production.
    • Erythrocyte membrane oral therapy was the intervention used.
    • Four cases of severe Rh disease were managed.

    Conclusions:

    • Erythrocyte membrane oral therapy was investigated as a management strategy for severe Rh disease.
    • The primary objective was to decrease anti-D antibody production.
    • Further research may be warranted to establish the full potential of this therapy.

    Related Experiment Videos